Literature DB >> 19196745

Alzheimer's disease.

Alistair Burns1, Steve Iliffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196745     DOI: 10.1136/bmj.b158

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  209 in total

1.  Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Authors:  Gary Naglie; David B Hogan; Murray Krahn; B Lynn Beattie; Sandra E Black; Chris Macknight; Morris Freedman; Christopher Patterson; Michael Borrie; Howard Bergman; Anna Byszewski; David Streiner; Jane Irvine; Paul Ritvo; Janna Comrie; Matthew Kowgier; George Tomlinson
Journal:  Am J Geriatr Psychiatry       Date:  2011-10       Impact factor: 4.105

Review 2.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

3.  Alzheimer disease: Perceived efficacy of antidementia drug treatment.

Authors:  Kevina McAvinchey; Alistair Burns
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

4.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

Review 5.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  Zinc and its effects on oxidative stress in Alzheimer's disease.

Authors:  Ye Yuan; Fenglan Niu; Ya Liu; Na Lu
Journal:  Neurol Sci       Date:  2014-02-13       Impact factor: 3.307

7.  Profiling of Differential Expression of Genes in Mice Carrying Both Mutant Presenilin 1 and Amyloid Precursor Protein Transgenes with or without Knockout of B2 Adrenergic Receptor Gene.

Authors:  Yuan Zhou; Lintao Chen; Xi Zhou; Yechun Pei; Shuangshuang Wei; Anum Mehmood; Yang K Xiang; Dayong Wang
Journal:  J Appl Bioinforma Comput Biol       Date:  2018-09-18

Review 8.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

9.  Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese.

Authors:  Qun Xiang; Rui Bi; Min Xu; Deng-Feng Zhang; Liwen Tan; Chen Zhang; Yiru Fang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

10.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.